The Curbsiders Internal Medicine Podcast

#361 Advanced Lipidology

Oct 24, 2022

1:18:28

Episode Description

Lipids Update 2022: Cardiovascular Risk Reduction and New Medications on the Horizon with Erin Michos, MD

Show description:
Ready to take the next step in management of your patient with hyperlipidemia? Dr. Erin Michos (@erinmichos) returns to give us a lesson in Advanced Lipidology. She updates us on what new medications we can use for those difficult to treat lipids and what medications are on the horizon.

Unfortunately, this episode will not be available for CME. You can claim free CME for other episodes at curbsiders.vcuhealth.org!

Episodes | Subscribe | Spotify | Swag! | Top Picks | Mailing List | askcurbsiders@gmail.com | Free CME!

Show Segments

Intro, Getting to know Dr. Erin Michos, Pick of the Week
Patient Case, Digging into ASCVD Risk
Coronary artery calcium scoring - why it’s important
What are “Risk Enhancing Factors”?
Biomarker testing, what is the significance of Lip a and how can we use it to drive management?
Introduction to PCSK9 inhibitors
More than just statins - other LDL-lowering medications
siRNAs, ASOs - Pelacarsen and more
Apollo Trial regarding Pelacarsen
Importance of Family History
What to do if maxed out on a statin or statin intolerance - Ezetimibe, PCSK9 inhibitors, MAB therapies, and more
Bempedoic Acid discussion
Medication side effects
Homozygous FH - approach to treatment, ANGPTL3 inhibitors
Triglycerides discussion, icosapent ethyl, the REDUCE-IT trial
Wrap-up and Take home points, Outtro